These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19794435)

  • 1. Mixed results for novel CD20-targeted antibody.
    Nat Rev Drug Discov; 2009 Oct; 8(10):762. PubMed ID: 19794435
    [No Abstract]   [Full Text] [Related]  

  • 2. [CD20 antibody for treatment of rheumatoid arthritis].
    Tanaka Y
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():544-8. PubMed ID: 15799415
    [No Abstract]   [Full Text] [Related]  

  • 3. Perspectives of ofatumumab as CD20 targeted therapy in rheumatoid arthritis and other autoimmune diseases.
    Pers YM; Jorgensen C
    Immunotherapy; 2016 Sep; 8(9):1091-6. PubMed ID: 27485081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD20-targeted therapy: a breakthrough in the treatment of non-Hodgkin's lymphoma.
    van Meerten T; Hagenbeek A
    Neth J Med; 2009; 67(7):251-9. PubMed ID: 19687518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rituximab treatment of rheumatoid arthritis: new evidence].
    Nasonov EL
    Ter Arkh; 2009; 81(6):82-91. PubMed ID: 19663200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRU-015, a fusion protein derived from an anti-CD20 antibody, for the treatment of rheumatoid arthritis.
    Rubbert-Roth A
    Curr Opin Mol Ther; 2010 Feb; 12(1):115-23. PubMed ID: 20140823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-CD20 therapy in rheumatoid arthritis].
    Roll P; Tony HP
    Z Rheumatol; 2009 Jul; 68(5):370-9. PubMed ID: 19449019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience.
    Shaw T; Quan J; Totoritis MC
    Ann Rheum Dis; 2003 Nov; 62 Suppl 2(Suppl 2):ii55-9. PubMed ID: 14532151
    [No Abstract]   [Full Text] [Related]  

  • 9. [Targeted therapy of neoplasms and pharmacopathology].
    Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2005 Aug; 34(8):468-70. PubMed ID: 16383287
    [No Abstract]   [Full Text] [Related]  

  • 10. Rituximab for rheumatoid arthritis.
    Palylyk-Colwell E; McGahan L
    Issues Emerg Health Technol; 2006 Sep; (89):1-4. PubMed ID: 17014062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cell-directed therapy in rheumatoid arthritis--clinical experience.
    Panayi GS
    J Rheumatol Suppl; 2005 Feb; 73():19-24; discussion 29-30. PubMed ID: 15693112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-CD20 antibody therapy for inflammatory immune diseases].
    Tanaka Y
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1801-6. PubMed ID: 17037318
    [No Abstract]   [Full Text] [Related]  

  • 13. B lymphocyte depletion in rheumatoid arthritis: targeting of CD20.
    Edwards JC; Leandro MJ; Cambridge G
    Curr Dir Autoimmun; 2005; 8():175-92. PubMed ID: 15564721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current aspects of anti-CD20 therapy in rheumatoid arthritis.
    Jacobi AM; Dörner T
    Curr Opin Pharmacol; 2010 Jun; 10(3):316-21. PubMed ID: 20189875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD20 as a target for therapeutic type I and II monoclonal antibodies.
    Beers SA; Chan CH; French RR; Cragg MS; Glennie MJ
    Semin Hematol; 2010 Apr; 47(2):107-14. PubMed ID: 20350657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cells, be gone--B-cell depletion in the treatment of rheumatoid arthritis.
    Tsokos GC
    N Engl J Med; 2004 Jun; 350(25):2546-8. PubMed ID: 15201410
    [No Abstract]   [Full Text] [Related]  

  • 17. Emerging biologic drugs for the treatment of rheumatoid arthritis.
    Puppo F; Murdaca G; Ghio M; Indiveri F
    Autoimmun Rev; 2005 Nov; 4(8):537-41. PubMed ID: 16214092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphomatoid granulomatosis in a patient with rheumatoid arthritis receiving methotrexate: successful treatment with the anti-CD20 antibody mabthera.
    Schalk E; Krogel C; Scheinpflug K; Mohren M
    Onkologie; 2009 Jul; 32(7):440-1. PubMed ID: 19556825
    [No Abstract]   [Full Text] [Related]  

  • 19. Rituximab: in rheumatoid arthritis.
    Frampton JE; Scott LJ
    BioDrugs; 2007; 21(5):333-41: discussion 342. PubMed ID: 17896839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD19: a promising B cell target for rheumatoid arthritis.
    Tedder TF
    Nat Rev Rheumatol; 2009 Oct; 5(10):572-7. PubMed ID: 19798033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.